ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Failure of the ‘Pharmacy of the South’

Some of the issues in pharmaceutical industries, the supply chain of drugs and the access of essential medicines among the Indian population are explored. Further, the roles of the regulator are also discussed in their production and distribution.

The author is grateful to the anonymous referee for their detailed comments.

The author acknowledges the IoE Project (Ministry of Education, Government of India), University of Hyderabad, India for financial support with grant no UoH/IoE/RC2/-21-004. The grant agency has no role in designing and conduct of the study.

 

Indian pharmaceutical industry is known as sunrise sector for its high growth and revenue at the international level (Indian Pharmaceutical Alliance 2019). Though it grew at a slower pace in the post-independence era, it gained momentum after the 1980s with a favourable patent regime (CII 2017; Indian Pharmaceutical Alliance 2019). The export of pharmaceutical products rose faster with high demand in developing and developed countries due to the acceptable quality of Indian pharmaceutical companies.

To be precise, the Indian pharmaceutical companies comply with all international Food and Drug Administration (FDA) standards across many countries and regions. Hence, the safety and efficacy of Indian pharmaceutical products is the key to galvanising the industry. The multinational companies also got populated on Indian soil to harness the advantages of cheap labour force, hassle-free manufacturing licences, and efficient trade regulations by the government.

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Or

To gain instant access to this article (download).

Pay INR 50.00

(Readers in India)

Pay $ 6.00

(Readers outside India)

Updated On : 29th May, 2023
Back to Top